Global Oncology Biosimilars Market Insights and Forecast to 2028

Global Oncology Biosimilars Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Oncology Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Oncology Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibody
1.2.3 Hematopoietic Agents
1.2.4 G-CSF
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncology Biosimilars Sales Estimates and Forecasts 2017-2028
2.2 Global Oncology Biosimilars Revenue Estimates and Forecasts 2017-2028
2.3 Global Oncology Biosimilars Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oncology Biosimilars Sales by Region
2.4.1 Global Oncology Biosimilars Sales by Region (2017-2022)
2.4.2 Global Sales Oncology Biosimilars by Region (2023-2028)
2.5 Global Oncology Biosimilars Revenue by Region
2.5.1 Global Oncology Biosimilars Revenue by Region (2017-2022)
2.5.2 Global Oncology Biosimilars Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oncology Biosimilars Sales by Manufacturers
3.1.1 Global Top Oncology Biosimilars Manufacturers by Sales (2017-2022)
3.1.2 Global Oncology Biosimilars Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oncology Biosimilars in 2021
3.2 Global Oncology Biosimilars Revenue by Manufacturers
3.2.1 Global Oncology Biosimilars Revenue by Manufacturers (2017-2022)
3.2.2 Global Oncology Biosimilars Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oncology Biosimilars Revenue in 2021
3.3 Global Oncology Biosimilars Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oncology Biosimilars Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oncology Biosimilars Sales by Type
4.1.1 Global Oncology Biosimilars Historical Sales by Type (2017-2022)
4.1.2 Global Oncology Biosimilars Forecasted Sales by Type (2023-2028)
4.1.3 Global Oncology Biosimilars Sales Market Share by Type (2017-2028)
4.2 Global Oncology Biosimilars Revenue by Type
4.2.1 Global Oncology Biosimilars Historical Revenue by Type (2017-2022)
4.2.2 Global Oncology Biosimilars Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oncology Biosimilars Revenue Market Share by Type (2017-2028)
4.3 Global Oncology Biosimilars Price by Type
4.3.1 Global Oncology Biosimilars Price by Type (2017-2022)
4.3.2 Global Oncology Biosimilars Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oncology Biosimilars Sales by Application
5.1.1 Global Oncology Biosimilars Historical Sales by Application (2017-2022)
5.1.2 Global Oncology Biosimilars Forecasted Sales by Application (2023-2028)
5.1.3 Global Oncology Biosimilars Sales Market Share by Application (2017-2028)
5.2 Global Oncology Biosimilars Revenue by Application
5.2.1 Global Oncology Biosimilars Historical Revenue by Application (2017-2022)
5.2.2 Global Oncology Biosimilars Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oncology Biosimilars Revenue Market Share by Application (2017-2028)
5.3 Global Oncology Biosimilars Price by Application
5.3.1 Global Oncology Biosimilars Price by Application (2017-2022)
5.3.2 Global Oncology Biosimilars Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oncology Biosimilars Market Size by Type
6.1.1 North America Oncology Biosimilars Sales by Type (2017-2028)
6.1.2 North America Oncology Biosimilars Revenue by Type (2017-2028)
6.2 North America Oncology Biosimilars Market Size by Application
6.2.1 North America Oncology Biosimilars Sales by Application (2017-2028)
6.2.2 North America Oncology Biosimilars Revenue by Application (2017-2028)
6.3 North America Oncology Biosimilars Market Size by Country
6.3.1 North America Oncology Biosimilars Sales by Country (2017-2028)
6.3.2 North America Oncology Biosimilars Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oncology Biosimilars Market Size by Type
7.1.1 Europe Oncology Biosimilars Sales by Type (2017-2028)
7.1.2 Europe Oncology Biosimilars Revenue by Type (2017-2028)
7.2 Europe Oncology Biosimilars Market Size by Application
7.2.1 Europe Oncology Biosimilars Sales by Application (2017-2028)
7.2.2 Europe Oncology Biosimilars Revenue by Application (2017-2028)
7.3 Europe Oncology Biosimilars Market Size by Country
7.3.1 Europe Oncology Biosimilars Sales by Country (2017-2028)
7.3.2 Europe Oncology Biosimilars Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oncology Biosimilars Market Size by Type
8.1.1 Asia Pacific Oncology Biosimilars Sales by Type (2017-2028)
8.1.2 Asia Pacific Oncology Biosimilars Revenue by Type (2017-2028)
8.2 Asia Pacific Oncology Biosimilars Market Size by Application
8.2.1 Asia Pacific Oncology Biosimilars Sales by Application (2017-2028)
8.2.2 Asia Pacific Oncology Biosimilars Revenue by Application (2017-2028)
8.3 Asia Pacific Oncology Biosimilars Market Size by Region
8.3.1 Asia Pacific Oncology Biosimilars Sales by Region (2017-2028)
8.3.2 Asia Pacific Oncology Biosimilars Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oncology Biosimilars Market Size by Type
9.1.1 Latin America Oncology Biosimilars Sales by Type (2017-2028)
9.1.2 Latin America Oncology Biosimilars Revenue by Type (2017-2028)
9.2 Latin America Oncology Biosimilars Market Size by Application
9.2.1 Latin America Oncology Biosimilars Sales by Application (2017-2028)
9.2.2 Latin America Oncology Biosimilars Revenue by Application (2017-2028)
9.3 Latin America Oncology Biosimilars Market Size by Country
9.3.1 Latin America Oncology Biosimilars Sales by Country (2017-2028)
9.3.2 Latin America Oncology Biosimilars Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oncology Biosimilars Market Size by Type
10.1.1 Middle East and Africa Oncology Biosimilars Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oncology Biosimilars Revenue by Type (2017-2028)
10.2 Middle East and Africa Oncology Biosimilars Market Size by Application
10.2.1 Middle East and Africa Oncology Biosimilars Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oncology Biosimilars Revenue by Application (2017-2028)
10.3 Middle East and Africa Oncology Biosimilars Market Size by Country
10.3.1 Middle East and Africa Oncology Biosimilars Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oncology Biosimilars Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Celltrion
11.1.1 Celltrion Corporation Information
11.1.2 Celltrion Overview
11.1.3 Celltrion Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Celltrion Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Celltrion Recent Developments
11.2 Biocon
11.2.1 Biocon Corporation Information
11.2.2 Biocon Overview
11.2.3 Biocon Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biocon Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biocon Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr. Reddy's Laboratories Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 STADA Arzneimittel AG
11.4.1 STADA Arzneimittel AG Corporation Information
11.4.2 STADA Arzneimittel AG Overview
11.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 STADA Arzneimittel AG Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 STADA Arzneimittel AG Recent Developments
11.5 Intas Pharmaceuticals
11.5.1 Intas Pharmaceuticals Corporation Information
11.5.2 Intas Pharmaceuticals Overview
11.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Intas Pharmaceuticals Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Intas Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Sandoz International
11.7.1 Sandoz International Corporation Information
11.7.2 Sandoz International Overview
11.7.3 Sandoz International Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sandoz International Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sandoz International Recent Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.8.2 Teva Pharmaceutical Industries Ltd Overview
11.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 BIOCAD
11.10.1 BIOCAD Corporation Information
11.10.2 BIOCAD Overview
11.10.3 BIOCAD Oncology Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BIOCAD Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BIOCAD Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oncology Biosimilars Industry Chain Analysis
12.2 Oncology Biosimilars Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oncology Biosimilars Production Mode & Process
12.4 Oncology Biosimilars Sales and Marketing
12.4.1 Oncology Biosimilars Sales Channels
12.4.2 Oncology Biosimilars Distributors
12.5 Oncology Biosimilars Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oncology Biosimilars Industry Trends
13.2 Oncology Biosimilars Market Drivers
13.3 Oncology Biosimilars Market Challenges
13.4 Oncology Biosimilars Market Restraints
14 Key Findings in The Global Oncology Biosimilars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oncology Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibody
Table 3. Major Manufacturers of Hematopoietic Agents
Table 4. Major Manufacturers of G-CSF
Table 5. Major Manufacturers of Others
Table 6. Global Oncology Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oncology Biosimilars Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oncology Biosimilars Sales by Region (2017-2022) & (K Units)
Table 9. Global Oncology Biosimilars Sales Market Share by Region (2017-2022)
Table 10. Global Oncology Biosimilars Sales by Region (2023-2028) & (K Units)
Table 11. Global Oncology Biosimilars Sales Market Share by Region (2023-2028)
Table 12. Global Oncology Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Oncology Biosimilars Revenue Market Share by Region (2017-2022)
Table 14. Global Oncology Biosimilars Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Oncology Biosimilars Revenue Market Share by Region (2023-2028)
Table 16. Global Oncology Biosimilars Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Oncology Biosimilars Sales Share by Manufacturers (2017-2022)
Table 18. Global Oncology Biosimilars Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Oncology Biosimilars Revenue Share by Manufacturers (2017-2022)
Table 20. Oncology Biosimilars Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oncology Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Biosimilars as of 2021)
Table 23. Oncology Biosimilars Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oncology Biosimilars Product Offered
Table 25. Date of Manufacturers Enter into Oncology Biosimilars Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 28. Global Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 29. Global Oncology Biosimilars Sales Share by Type (2017-2022)
Table 30. Global Oncology Biosimilars Sales Share by Type (2023-2028)
Table 31. Global Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Oncology Biosimilars Revenue Share by Type (2017-2022)
Table 34. Global Oncology Biosimilars Revenue Share by Type (2023-2028)
Table 35. Oncology Biosimilars Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Oncology Biosimilars Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 38. Global Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 39. Global Oncology Biosimilars Sales Share by Application (2017-2022)
Table 40. Global Oncology Biosimilars Sales Share by Application (2023-2028)
Table 41. Global Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Oncology Biosimilars Revenue Share by Application (2017-2022)
Table 44. Global Oncology Biosimilars Revenue Share by Application (2023-2028)
Table 45. Oncology Biosimilars Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Oncology Biosimilars Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 48. North America Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 49. North America Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 52. North America Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 53. North America Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Oncology Biosimilars Sales by Country (2017-2022) & (K Units)
Table 56. North America Oncology Biosimilars Sales by Country (2023-2028) & (K Units)
Table 57. North America Oncology Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Oncology Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 60. Europe Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 61. Europe Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 64. Europe Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 65. Europe Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Oncology Biosimilars Sales by Country (2017-2022) & (K Units)
Table 68. Europe Oncology Biosimilars Sales by Country (2023-2028) & (K Units)
Table 69. Europe Oncology Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Oncology Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Oncology Biosimilars Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Oncology Biosimilars Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Oncology Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Oncology Biosimilars Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Oncology Biosimilars Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Oncology Biosimilars Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Oncology Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Oncology Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Oncology Biosimilars Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Oncology Biosimilars Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Oncology Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Oncology Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Oncology Biosimilars Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Oncology Biosimilars Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Oncology Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Oncology Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Oncology Biosimilars Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Oncology Biosimilars Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Oncology Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Oncology Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 107. Celltrion Corporation Information
Table 108. Celltrion Description and Major Businesses
Table 109. Celltrion Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Celltrion Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Celltrion Recent Developments
Table 112. Biocon Corporation Information
Table 113. Biocon Description and Major Businesses
Table 114. Biocon Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Biocon Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Biocon Recent Developments
Table 117. Dr. Reddy's Laboratories Corporation Information
Table 118. Dr. Reddy's Laboratories Description and Major Businesses
Table 119. Dr. Reddy's Laboratories Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Dr. Reddy's Laboratories Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Dr. Reddy's Laboratories Recent Developments
Table 122. STADA Arzneimittel AG Corporation Information
Table 123. STADA Arzneimittel AG Description and Major Businesses
Table 124. STADA Arzneimittel AG Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. STADA Arzneimittel AG Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. STADA Arzneimittel AG Recent Developments
Table 127. Intas Pharmaceuticals Corporation Information
Table 128. Intas Pharmaceuticals Description and Major Businesses
Table 129. Intas Pharmaceuticals Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Intas Pharmaceuticals Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Intas Pharmaceuticals Recent Developments
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Major Businesses
Table 134. Pfizer Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Pfizer Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Pfizer Recent Developments
Table 137. Sandoz International Corporation Information
Table 138. Sandoz International Description and Major Businesses
Table 139. Sandoz International Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Sandoz International Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Sandoz International Recent Developments
Table 142. Teva Pharmaceutical Industries Ltd Corporation Information
Table 143. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 144. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Teva Pharmaceutical Industries Ltd Recent Developments
Table 147. Apotex Corporation Information
Table 148. Apotex Description and Major Businesses
Table 149. Apotex Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Apotex Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Apotex Recent Developments
Table 152. BIOCAD Corporation Information
Table 153. BIOCAD Description and Major Businesses
Table 154. BIOCAD Oncology Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. BIOCAD Oncology Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. BIOCAD Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Oncology Biosimilars Distributors List
Table 160. Oncology Biosimilars Customers List
Table 161. Oncology Biosimilars Market Trends
Table 162. Oncology Biosimilars Market Drivers
Table 163. Oncology Biosimilars Market Challenges
Table 164. Oncology Biosimilars Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Biosimilars Product Picture
Figure 3. Global Oncology Biosimilars Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Antibody Product Picture
Figure 4. Hematopoietic Agents Product Picture
Figure 5. G-CSF Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oncology Biosimilars Market Share by Application in 2021 & 2028
Figure 8. Retail Pharmacies
Figure 9. Hospital Pharmacy
Figure 10. Online Pharmacy
Figure 11. Oncology Biosimilars Report Years Considered
Figure 12. Global Oncology Biosimilars Sales 2017-2028 (K Units)
Figure 13. Global Oncology Biosimilars Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oncology Biosimilars Revenue 2017-2028 (US$ Million)
Figure 15. Global Oncology Biosimilars Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Oncology Biosimilars Sales Market Share by Region (2017-2022)
Figure 17. Global Oncology Biosimilars Sales Market Share by Region (2023-2028)
Figure 18. North America Oncology Biosimilars Sales YoY (2017-2028) & (K Units)
Figure 19. North America Oncology Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Oncology Biosimilars Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Oncology Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Oncology Biosimilars Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Oncology Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Oncology Biosimilars Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Oncology Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Oncology Biosimilars Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Oncology Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Oncology Biosimilars Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Oncology Biosimilars in the World: Market Share by Oncology Biosimilars Revenue in 2021
Figure 30. Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Oncology Biosimilars Sales Market Share by Type (2017-2028)
Figure 32. Global Oncology Biosimilars Revenue Market Share by Type (2017-2028)
Figure 33. Global Oncology Biosimilars Sales Market Share by Application (2017-2028)
Figure 34. Global Oncology Biosimilars Revenue Market Share by Application (2017-2028)
Figure 35. North America Oncology Biosimilars Sales Market Share by Type (2017-2028)
Figure 36. North America Oncology Biosimilars Revenue Market Share by Type (2017-2028)
Figure 37. North America Oncology Biosimilars Sales Market Share by Application (2017-2028)
Figure 38. North America Oncology Biosimilars Revenue Market Share by Application (2017-2028)
Figure 39. North America Oncology Biosimilars Sales Share by Country (2017-2028)
Figure 40. North America Oncology Biosimilars Revenue Share by Country (2017-2028)
Figure 41. U.S. Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Oncology Biosimilars Sales Market Share by Type (2017-2028)
Figure 44. Europe Oncology Biosimilars Revenue Market Share by Type (2017-2028)
Figure 45. Europe Oncology Biosimilars Sales Market Share by Application (2017-2028)
Figure 46. Europe Oncology Biosimilars Revenue Market Share by Application (2017-2028)
Figure 47. Europe Oncology Biosimilars Sales Share by Country (2017-2028)
Figure 48. Europe Oncology Biosimilars Revenue Share by Country (2017-2028)
Figure 49. Germany Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 50. France Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Oncology Biosimilars Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Oncology Biosimilars Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Oncology Biosimilars Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Oncology Biosimilars Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Oncology Biosimilars Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Oncology Biosimilars Revenue Share by Region (2017-2028)
Figure 60. China Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Oncology Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 63.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs